EasyDNNNews

Thursday, May 31, 2018

False-Positive Breast Biopsies May Cost US Healthcare System $2.18 Billion, Study Suggests.

The Radiology Business Journal (5/31, Walter) reports researchers found that “false-positive breast biopsies cost the US healthcare system approximately $2.18 billion each year.” The findings were published in ClinicoEconomics and Outcomes Research.

Print
Author: Nicole Hardy
0 Comments

Categories: 2018, May, News, Screening and MammographyNumber of views: 2076

Tags:

Theme picker